Leading Coronavirus Vaccine Researcher to Speak at Andrews University
Written by:
January 23, 2021
On Thursday, Jan. 28, 2021, at 4:30 p.m. (EST), the Andrews University Department of Chemistry & Biochemistry will host an online presentation by Kizzmekia Shanta Corbett, PhD, senior research fellow and team lead for coronavirus research within the Viral Pathogenesis Laboratory (VPL) at the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID). Corbett will address the safety and effectiveness of the coronavirus vaccines.
Dr. Anthony Fauci, current director of the National Institute of Allergy and Infectious Diseases (NIAID), the chief medical adviser designate to the incoming Biden–Harris administration, who has served American public health for over 50 years, has spoken glowingly about Corbett: Kizzy is an African American scientist who is right at the forefront of the development of the vaccine. The very vaccine that s one of the two that ha
The U.S. new cases 7-day rolling average are 21.7 % LOWER than the 7-day rolling average one week ago. U.S. hospitalizations due to COVID-19 are now 4.4 %
LOWER than the rolling average one week ago. U.S. deaths due to coronavirus are now 11.0 %
LOWER than the rolling average one week ago. Today s posts include:
U.S. Coronavirus New Cases are 188,952
U.S. Coronavirus hospitalizations are at an elevated 119,927
U.S. Coronavirus deaths are at an elevated 3,955
U.S. Coronavirus immunizations have been administered to 5.3 % of the population
The 7-day rolling average rate of growth of the pandemic shows new cases improved, hospitalizations improved, and deaths worsened
The University of North Carolina at Chapel Hill announced Friday that it avoided returning to campus 112 undergraduate students who tested positive for the coronavirus through its newly launched mass testing program.
Division Director
Dr. Stephanie R. Bialek, MD, MPH, is the director of the Division of Viral Diseases in CDC’s National Center for Immunization and Respiratory Diseases (NCIRD), since 2020. Dr. Bialek, a captain in the United States Public Health Service, leads a division with 4 branches, 27 programs, and over 300 staff, fellows, and contractors.
During her career, Dr. Bialek has worked on a wide range of domestic and international public health programs. She joined CDC as an Epidemic Intelligence Service officer in 1999 and worked in the Division of Viral Hepatitis. After completing the practicum year of her residency in Preventive Medicine at the Georgia Department of Public Health in 2003, Dr. Bialek returned to the Division of Viral Hepatitis as a medical epidemiologist working on hepatitis B vaccine effectiveness and chronic hepatitis B and C.
Researchers identify genetic risk factors contributing to pneumonia susceptibility and severity
Researchers at Vanderbilt University Medical Center and colleagues have identified genetic factors that increase the risk for developing pneumonia and its severe, life-threatening consequences.
Their findings, published recently in the
American Journal of Human Genetics, may aid efforts to identify patients with COVID-19 at greatest risk for pneumonia, and enable earlier interventions to prevent severe illness and death.
Despite the increasing availability of COVID-19 vaccines, it will take months to inoculate enough people to bring the pandemic under control, experts predict. In the meantime, thousands of Americans are hospitalized and die from COVID-19 each day.